6550--Roche Ventana Reagents - Source Sought Notice New Orleans VAMC
Veterans Affairs · 256-NETWORK CONTRACT OFFICE 16 (36C256)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25627Q0038 in this department, oldest first.
- Oct 5, 2026 · this noticePre-solicitation
- Oct 6, 2026Pre-solicitationOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
This is a SOURCES SOUGHT NOTICE ONLY.� This SOURCE SOUGHT NOTICE is for the purpose of Market Research. Response to this notice will be used for information and planning purposes and issued in accordance with Federal Acquisition Regulation (FAR) Part 10- Market Research, in order to conduct market research. No proposals or quotes are being requested or accepted with this notice. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. This RFI is issued solely for information and planning purposes and does not constitute a solicitation or a g… (show all)
uarantee to issue a solicitation in the future. This RFI does not commit the Government to contract for any supply or service. All information submitted in response to this announcement is voluntary; the Government will not pay for information requested nor will it compensate any respondent for any cost incurred in developing information provided to the Government. Not responding to this RFI does not preclude participation in any future solicitation, if issued. This announcement is based on the best information available at this time and is subject to future modification. This notice shall NOT be construed as solicitation or as an obligation on the part of the Department of Veterans Affairs (VA). Responses to this notice is not a request to be added to a prospective bidders list or to receive a copy of the solicitation. The purpose of this synopsis is to gain knowledge of potential qualified sources and their size classification, Service Disabled/Veteran Owned Small Business. (SDVOSB/VOSB), HUBZone, 8(a), small, small disadvantage, woman owned small business, or large business) relative to NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing) and the size standard is 1,250 Employees. The Product Service Code (PSC) is 6550, In-Vitro Diagnostic Substance Reagents, Test Kits, and Sets. Requirement: The purpose of this requirement is to provide Immunohistochemistry (IHC) and Special Stain reagents for Roche Ventana staining platforms located within the Anatomic Pathology Section of the Southeast Louisiana Veterans Health Care System (SLVHCS), 2400 Canal Street, New Orleans, Louisiana 70119. Responses must be received by no later than 16:00 p.m. Central Standard Time, Friday, 9 October, 2025. Responses shall be emailed to Christopher.Rossi2@va.gov Capabilities Statements to include UEI number. Facsimile or Telephonic responses will not be accepted. Note: All interested parties are reminded to be registered, active and verified in the following to be considered for Award (as applicable). SAM: https://www.sam.gov/portal/public/SAM/ This RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. No quotes will be accepted.
Who won similar work
89 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Veterans Affairs), same product/service code (PSC) 6550.
Single-winner award sizes (87): middle half $377K to $1.3M, median $688K; range $30K to $151.7M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| CEPHEID SUNNYVALE 94089 | 11 | $26.2M | Apr 15, 2026 |
| ROCHE DIAGNOSTICS CORPORATION | 11 | $14.7M | Aug 28, 2026 |
| BECKMAN COULTER, INC. | 11 | $6.8M | Oct 2, 2026 |
| BIOMERIEUX INC | 5 | $9.8M | Oct 1, 2026 |
| CEPHEID Sunnyvale CA 94089 USA | 4 | $40.5M | Jun 26, 2026 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 4 | $5.2M | Jun 2, 2026 |
| POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 3 | $4.5M | Apr 9, 2026 |
| WERFEN USA LLC | 3 | $2.6M | Oct 1, 2026 |
| TOSOH BIOSCIENCE, INC. | 2 | $4.1M | Mar 18, 2026 |
| SIEMENS HEALTHCARE DIAGNOSTICS INC. | 2 | $2.5M | Oct 1, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- Oct 6, 2026ABBOTT MOLECULAR INC.$920K6550--LAB - ABBOTT ALINITY-M PCR MOLECULAR REAGENTS & SUPPLIESMateriality: <0.01% of $ABT revenue (Low) SEC
- Oct 2, 2026BECKMAN COULTER, INC.$291K6550--Intent to Sole Source | 3 Month Bridge Philadelphia VA Medical Center Laboratory Hematology/Chemistry TestingNo listed company matched (Materiality N/A)
- Oct 1, 2026BECKMAN COULTER, INC$700KDrugs of Abuse ReagentsNo listed company matched (Materiality N/A)
- Oct 1, 2026WERFEN USA LLC$388K6550--Werfen Immunocor Blood Bank Reagents and Supplies Northport and East OrangeNo listed company matched (Materiality N/A)
- Oct 1, 2026BIOMERIEUX INC$284K6550--DO Biofire Panel Kits in support of the Sioux Falls VA HCSNo listed company matched (Materiality N/A)
- Oct 1, 2026QUIDELORTHO SALES COMPANY$125K6550--Blood Bank Reagents 5 Year OP IDIQ - DetroitMateriality: <0.01% of $QDEL revenue (Low) SEC
- Oct 1, 2026SIEMENS HEALTHCARE DIAGNOSTICS INC.$600K6550--Blood Gas Analyzer Reagents, Controls, and Supplies IDIQNo listed company matched (Materiality N/A)
- Sep 28, 2026NOVA BIOMEDICAL CORP$1.1M6550--Glucose Point of Care (POC) TestingNo listed company matched (Materiality N/A)
- Aug 28, 2026ROCHE DIAGNOSTICS CORPORATION$107K6550--Glucose Accu-Chek® Test StripsNo listed company matched (Materiality N/A)
- Aug 17, 2026WERFEN USA LLC$1.4M6550--Blood Type IVD ReagentsNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (6 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.